Export

Vertex Pharmaceuticals (Sweden) AB

Financial information

The information source is the annual report of the company with business id 556991-2024

* Closing information (×1000) SEK

Fiscal year 202412 202312
Number of months: 12 12
Turnover: 68,717 Revenue Up 58,242 Revenue Up
Financial expenses: 2 Revenue Down 332 Revenue Up
Earnings before taxes: 4,907 Revenue Up 3,832 Revenue Up
Total assets: 36,430 Revenue Up 32,610 Revenue Down
Current assets: 36,353 Revenue Up 32,342 Revenue Down
Current liabilities: 16,304 Revenue Up 16,250 Revenue Down
Equity capital: 20,126 Revenue Up 16,360 Revenue Up
Share capital: 50 50
Number of employees: 11 Revenue Up 9 Revenue Up

Financial ratios

Solvency: 55.2% Revenue Up 50.2% Revenue Up
Turnover per employee: 6,247 Revenue Down 6,471 Revenue Down
Profitability: 7.1% Revenue Up 6.6% Revenue Down
Return on equity (ROE): 24.4% Revenue Up 23.4% Revenue Down
Current ratio: 223.0% Revenue Up 199.0% Revenue Up
Return on assets (ROA): 13.5% Revenue Up 12.8% Revenue Up
Fiscal year 202412
Number of months: 12
Turnover: 68,717
Financial expenses: 2
Earnings before taxes: 4,907
Total assets: 36,430
Current assets: 36,353
Current liabilities: 16,304
Equity capital: 20,126
Share capital: 50
Number of employees: 11

Financial ratios

Solvency: 55.2%
Turnover per employee: 6,247
Profitability: 7.1%
Return on equity (ROE): 24.4%
Current ratio: 223.0%
Return on assets (ROA): 13.5%